AI-based clinician decision support system for diagnosis of inherited…
An AI system analyzing eye images helps eye specialists more accurately diagnose inherited retinal diseases before genetic testing, potentially speeding care for people with rare vision loss.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
MRD dynamics predicts progression and reveals a vulnerable state for…
Tracking cancer markers in blood over time identifies myeloma patients most likely to resist treatment, enabling earlier intervention with advanced therapies when they're most effective.
Early cancer detection or preventionTowards liquid biopsy-based analysis of antitumour immunity.
A framework for monitoring cancer-fighting immune cells in blood could help doctors personalize immunotherapy by detecting early signs of response or resistance without repeated biopsies.
Novel or significantly improved treatmentA Phase 1/1b Study of the All-Oral Regimen CC-486 and Venetoclax in…
The first all-oral blood cancer treatment combining two drugs offers older patients a simpler alternative to injections, potentially improving quality of life without sacrificing effectiveness.
Novel or significantly improved treatmentDurable responses to triplet immunotherapy targeting TGF-β, PD-L1,…
A three-pronged immunotherapy approach overcomes multiple immune barriers in prostate cancer, producing responses in patients who previously failed standard checkpoint therapy alone.